Dilaudid and Paroxysmal supraventricular tachycardia - a phase IV clinical study of FDA data

Summary:

Paroxysmal supraventricular tachycardia is found among people who take Dilaudid, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Dilaudid and have Paroxysmal supraventricular tachycardia. It is created by eHealthMe based on reports of 86,750 people who have side effects when taking Dilaudid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 20, 2023

86,750 people reported to have side effects when taking Dilaudid.
Among them, 45 people (0.05%) have Paroxysmal supraventricular tachycardia.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 87,690 Dilaudid users for its effectiveness, alternative drugs and more.

What is Paroxysmal supraventricular tachycardia?

Paroxysmal supraventricular tachycardia is found to be associated with 2,449 drugs and 1,788 conditions by eHealthMe.

Number of Dilaudid and Paroxysmal supraventricular tachycardia reports submitted per year:

Could Dilaudid cause Paroxysmal supraventricular tachycardia?

Time on Dilaudid when people have Paroxysmal supraventricular tachycardia *:

Gender of people who have Paroxysmal supraventricular tachycardia when taking Dilaudid *:

female: 68.18 %
male: 31.82 %

Age of people who have Paroxysmal supraventricular tachycardia when taking Dilaudid *:

Common drugs people take besides Dilaudid *:

Common side effects people have besides Paroxysmal supraventricular tachycardia *:

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 17 people, 37.78%
Nausea And Vomiting: 11 people, 24.44%
Insomnia (sleeplessness): 11 people, 24.44%
High Blood Pressure: 11 people, 24.44%
Nausea (feeling of having an urge to vomit): 10 people, 22.22%
Pleural Effusion (water on the lungs): 10 people, 22.22%
Hypotension (abnormally low blood pressure): 9 people, 20.00%
Cardiomyopathy (weakening of the heart muscle): 9 people, 20.00%
Urinary Tract Infection: 9 people, 20.00%
Cholecystitis (infection of gallbladder): 9 people, 20.00%

Common conditions people have *:

Nausea (feeling of having an urge to vomit): 10 people, 22.22%
Insomnia (sleeplessness): 4 people, 8.89%
Constipation: 4 people, 8.89%
Hypokalemia (low potassium): 3 people, 6.67%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 6.67%
High Blood Pressure: 3 people, 6.67%
Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 3 people, 6.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 6.67%
Chest Pain: 3 people, 6.67%
Headache (pain in head): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and have Paroxysmal supraventricular tachycardia?

Check whether Paroxysmal supraventricular tachycardia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Paroxysmal supraventricular tachycardia and when was it recovered:

Paroxysmal supraventricular tachycardia in Dilaudid

Expand to all the drugs that have ingredients of hydromorphone hydrochloride:

Paroxysmal supraventricular tachycardia and drugs with ingredients of hydromorphone hydrochloride (98 reports)

Alternative drugs to, pros and cons of Dilaudid:

Dilaudid (87,690 reports)

Common Dilaudid side effects:

Pain: 19,487 reports
Death: 15,862 reports
Stress and anxiety: 4,137 reports
Fatigue (feeling of tiredness): 3,611 reports

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Paroxysmal supraventricular tachycardia treatments and more:

Paroxysmal supraventricular tachycardia (15,798 reports)

COVID vaccines that are related to Paroxysmal supraventricular tachycardia:

Common drugs associated with Paroxysmal supraventricular tachycardia:

All the drugs that are associated with Paroxysmal supraventricular tachycardia:

Paroxysmal supraventricular tachycardia (2,449 drugs)

Common conditions associated with Paroxysmal supraventricular tachycardia:

High blood pressure: 570 reports
Diabetes: 369 reports
Osteoporosis: 363 reports
Pain: 339 reports
Primary pulmonary hypertension: 332 reports
Depression: 328 reports

All the conditions that are associated with Paroxysmal supraventricular tachycardia:

Paroxysmal supraventricular tachycardia (1,788 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride (the active ingredients of Dilaudid) and Dilaudid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.